Header Logo

Connection

MINI MICHAEL to RNA, Small Interfering

Back to Details
This is a "connection" page, showing publications MINI MICHAEL has written about RNA, Small Interfering.
MINI MICHAEL
Connection Strength
0.032
RNA, Small Interfering
  1. Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children. Genet Med. 2022 03; 24(3):654-662.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.